Cadence Neuroscience
SAMMAMISH, Washington, United States · Biotechnology
Cadence Neuroscience is a medical device company developing new therapies for the treatment of epilepsy and other neurological disorders. The company's core technology was developed at Mayo Clinic and is under clinical evaluation. Founded in 2017 and headquartered in Redmond, Washington, Cadence is led by seasoned executives with extensive backgrounds in neural implant product development and clin
Key facts
- Headquarters
- SAMMAMISH, Washington, United States
- Employees
- 22
- Industries
- Biotechnology
- Status
- Private
- Website
- cadenceneuro.com
- Company page
Recent activity at Cadence Neuroscience
Cadence Neuroscience funding history
| Date | Round | Amount |
|---|---|---|
| May 2023 | Series B | $26.0M |
| Feb 2023 | Venture | $26.0M |
| Sep 2019 | Seed | $3.0M |
| Jul 2017 | Venture | Undisclosed |
Leadership
- Kevin Chu, Director
- Gerry Brunk, Director
- John Harris, Director
- Kent Leyde, Executive Officer, Director
- Andrew Firlik, Director
- Warren Sheffield, Executive Officer, Director, Promoter
- Chris Cronin, Chief Executive Officer
Verified email and direct lines for Cadence Neuroscience’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Cadence Neuroscience in the news
- Cadence Neuroscience Appoints Medtech Executive Chris Cronin as CEO to Lead Clinical Execution and Platform Growth - PRWeb (Sep 22, 2026)
- Cadence Neuroscience Receives FDA IDE Approval to Begin Multicenter Study of its Biomarker Targeted Stimulation Therapy for Focal Drug-Resistant Epilepsy - PRWeb (Oct 14, 2026)
Companies similar to Cadence Neuroscience
- ABA Life · Biotechnology
- Versa Vascular · Biotechnology
- Dimerix Limited · Biotechnology
- N&E Innovations · Biotechnology
- Actuated Medical · Biotechnology
About Cadence Neuroscience: questions and answers
What does Cadence Neuroscience do?
Cadence Neuroscience is a medical device company developing new therapies for the treatment of epilepsy and other neurological disorders. The company's core technology was developed at Mayo Clinic and is under clinical evaluation. Founded in 2017 and headquartered in Redmond, Washington, Cadence is led by seasoned executives with extensive backgrounds in neural implant product development and clin
Where is Cadence Neuroscience headquartered?
Cadence Neuroscience is headquartered in SAMMAMISH, Washington, United States.
How many employees does Cadence Neuroscience have?
Cadence Neuroscience has about 22 employees.
Has Cadence Neuroscience raised funding?
Yes. Fundz has recorded 4 funding events for Cadence Neuroscience. The most recent, Series B of $26.0M, was in May 2023.
Who leads Cadence Neuroscience?
Chris Cronin is a Chief Executive Officer at Cadence Neuroscience.
What is the latest news on Cadence Neuroscience?
On Sep 22, 2026, Cadence Neuroscience Appoints Chris Cronin as Chief Executive Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy